Thomas Opladen

ORCID: 0000-0003-4349-7662
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Metabolism and Genetic Disorders
  • Amino Acid Enzymes and Metabolism
  • Genetic Neurodegenerative Diseases
  • Folate and B Vitamins Research
  • Mitochondrial Function and Pathology
  • Diet and metabolism studies
  • Genetics and Neurodevelopmental Disorders
  • Genomics and Rare Diseases
  • Biochemical and Molecular Research
  • Metabolomics and Mass Spectrometry Studies
  • Neonatal Health and Biochemistry
  • Neurological diseases and metabolism
  • Pluripotent Stem Cells Research
  • Pharmacological Effects and Toxicity Studies
  • Epigenetics and DNA Methylation
  • Genomic variations and chromosomal abnormalities
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • RNA modifications and cancer
  • CRISPR and Genetic Engineering
  • Neuroscience and Neuropharmacology Research
  • Biotin and Related Studies
  • Neurogenetic and Muscular Disorders Research
  • Neurological and metabolic disorders
  • Pancreatic function and diabetes

University Hospital Heidelberg
2016-2025

Heidelberg University
2016-2025

University Children's Hospital Zurich
2005-2023

Children's Clinical University Hospital
2020-2023

Uniwersytecki Szpital Dziecięcy
2020-2023

KK Women's and Children's Hospital
2023

Riyadh Armed Forces Hospital
2023

German Center for Pediatric and Adolescent Rheumatology
2021-2022

Heidelberg University
2021-2022

German Center for Neurodegenerative Diseases
2017

Michael Zech Robert Jech Sylvia Boesch Matěj Škorvánek Sandrina Weber and 95 more Matias Wagner Chen Zhao Angela Jochim Ján Necpál Yasemin Dincer Katharina Vill Felix Distelmaier Malgorzata Stoklosa Martin Krenn Stephan Grunwald Tobias Bock-Bierbaum Anna Fečíková Petra Havránková Jan Roth Iva Příhodová Miriam Adamovičová Olga Ulmanová Karel Bechyně Pavlína Danhofer Branislav Veselý Vladimír Haň Petra Pavelekova Zuzana Gdovinová Tobias Mantel Tobias Meindl Alexandra Sitzberger Sebastian Schröder Astrid Blaschek Timo Roser Michaela Bonfert Edda Haberlandt Barbara Plecko Birgit Leineweber Steffen Berweck T. Herberhold Berthold Langguth Jana Švantnerová Michal Minár Gonzalo Alonso Ramos-Rivera Monica H. Wojcik Sander Pajusalu Katrin Õunap Ulrich A. Schatz Laura Pölsler Ivan Milenković Franco Laccone Veronika Pilshofer Roberto Colombo Steffi Patzer Arcangela Iuso Julia Vera Mónica Troncoso Fang Fang Holger Prokisch Friederike Wilbert Matthias Eckenweiler Elisabeth Graf Dominik S. Westphal Korbinian M. Riedhammer Theresa Brunet Bader Alhaddad Riccardo Berutti Tim M. Strom Martin Hecht Matthias Baumann Marc E. Wolf Aida Telegrafi Richard Person Francisca Millan Zamora Lindsay B. Henderson David Weise Thomas Musacchio Jens Volkmann Anna Szuto Jessica Becker Kirsten Cremer Thomas Sycha Fritz Zimprich Verena Kraus Christine Makowski Pedro Gonzalez‐Alegre Tanya Bardakjian Laurie J. Ozelius Annalisa Vetro Renzo Guerrini Esther M. Maier Ingo Borggraefe Alice Kuster Saskia B. Wortmann Annette Hackenberg Robert Steinfeld Birgit Assmann Christian Staufner Thomas Opladen Evzen Růžička

10.1016/s1474-4422(20)30312-4 article EN The Lancet Neurology 2020-10-21

In infantile-onset cerebral folate deficiency, 5-methyltetrahydrofolate (5MTHF) levels in the cerebrospinal fluid are low, but serum and erythrocytes normal. We examined specimens from 28 children with 5 of their mothers, age-matched control subjects, 41 patients an unrelated neurologic disorder. Serum 25 0 subjects contained high-affinity blocking autoantibodies against membrane-bound receptors that present on choroid plexus. Oral folinic acid normalized 5MTHF led to clinical improvement....

10.1056/nejmoa043160 article EN New England Journal of Medicine 2005-05-11

GTP cyclohydrolase 1, encoded by the GCH1 gene, is an essential enzyme for dopamine production in nigrostriatal cells. Loss-of-function mutations result severe reduction of synthesis cells and are most common cause DOPA-responsive dystonia, a rare disease that classically presents childhood with generalized dystonia dramatic long-lasting response to levodopa. We describe clinical, genetic dopaminergic imaging ([123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) tropane single photon...

10.1093/brain/awu179 article EN cc-by Brain 2014-07-02

Leukoencephalopathy with brainstem and spinal cord involvement lactate elevation is a disorder caused by recessive mutations in the gene DARS2, which encodes mitochondrial aspartyl-tRNA synthetase. Recent observations indicate that phenotypic range of disease much wider than initially thought. Currently, no treatment available. The aims our study were (i) to explore possible genotype–phenotype correlation; (ii) identify potential therapeutic agents modulate splice site intron 2 present...

10.1093/brain/awu026 article EN Brain 2014-02-24

Aromatic l-amino acid decarboxylase deficiency (AADCD) is a rare, autosomal recessive neurodevelopmental disorder characterized by impaired synthesis of dopamine, noradrenaline, adrenaline and serotonin, leading to complex syndrome motor, behavioral, autonomic symptoms. This retrospective study assessed the symptoms developmental outcome large international cohort patients with AADCD via physician and/or caregiver responses detailed, standardized questionnaire. Sixty-three (60% female; ages...

10.1002/jimd.12247 article EN cc-by-nc Journal of Inherited Metabolic Disease 2020-05-05

Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare inherited metabolic disorder caused by defect of γ-aminobutyrate (GABA) catabolism. Despite the resultant hyper-GABAergic environment facilitated defect, individuals with this have paradoxically high prevalence epilepsy. We aimed to study characteristics epilepsy in SSADHD and its concordance GABA-related metabolites neurophysiologic markers cortical excitation.

10.1111/epi.17592 article EN Epilepsia 2023-03-24

Neurotransmitters are chemical messengers that enable communication between the neurons in synaptic cleft. Inborn errors of neurotransmitter biosynthesis, breakdown and transport a group very rare neurometabolic diseases resulting neurological impairment at any age from newborn to adulthood. The International Working Group on Neurotransmitter related Disorders (iNTD) is first international network focusing study primary secondary disorders. It was founded with aim foster exchange improve...

10.1016/j.ymgmr.2016.09.006 article EN cc-by-nc-nd Molecular Genetics and Metabolism Reports 2016-10-20

Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare autosomal recessive genetic disorder affecting the biosynthesis of dopamine, precursor both norepinephrine and epinephrine, serotonin. Diagnosis based on analysis CSF or plasma metabolites, AADC activity in testing for variants DDC gene. The exact prevalence deficiency, number patients, variant genotype are not known. Here, we present (n = 143) 151) 348 patients with 121 whom were previously reported. In addition, report 26 new...

10.1016/j.ymgme.2023.107624 article EN cc-by Molecular Genetics and Metabolism 2023-06-02

Abstract Background Succinic semialdehyde dehydrogenase deficiency (SSADHD) represents a model neurometabolic disease at the fulcrum of translational research within Boston Children’s Hospital Intellectual and Developmental Disabilities Research Centers (IDDRC), including NIH-sponsored natural history study clinical, neurophysiological, neuroimaging, molecular markers, patient-derived induced pluripotent stem cells (iPSC) characterization, development murine for tightly regulated,...

10.1186/s11689-024-09538-9 article EN cc-by Journal of Neurodevelopmental Disorders 2024-04-24

Abstract The objective of the study is to evaluate evolving phenotype and genetic spectrum patients with succinic semialdehyde dehydrogenase deficiency (SSADHD) in long‐term follow‐up. Longitudinal clinical biochemical data 22 pediatric 9 adult individuals SSADHD from patient registry International Working Group on Neurotransmitter related Disorders (iNTD) were studied silico analyses, pathogenicity scores molecular modeling ALDH5A1 variants. Leading initial symptoms, onset infancy,...

10.1002/jimd.12723 article EN cc-by-nc-nd Journal of Inherited Metabolic Disease 2024-03-18

Abstract This report details the case of an infant with confirmed propionic acidemia who presented progressive neurological deterioration and recurrent episodes metabolic decompensation elevated lactate levels, but without hyperammonemia. The child's clinical course neuroradiological findings increasingly deviated from known spectrum acidemia. A rapid trio exome sequencing identified SLC19A3 ‐related thiamine metabolism dysfunction syndrome 2 as a second genetic disease. pathomechanisms both...

10.1002/jmd2.12464 article EN cc-by JIMD Reports 2025-03-01

Abstract Background Patients with mutations in the monocarboxylate transporter 8 (MCT8, SLC16A2 ) suffer from X‐linked recessive Allan‐Herndon‐Dudley syndrome (AHDS), which is characterized by developmental delay and a severe movement disorder. Current trials using thyroid hormone derivatives to overcome defect have failed achieve patient‐oriented therapeutic goals. Objectives Our aim was define type of disorder AHDS an observational cohort study investigate causative role dopaminergic...

10.1002/mds.30152 article EN cc-by Movement Disorders 2025-03-15
Coming Soon ...